NCT03357302

Completed

Risk Factors Associated With the Global Burden of Disease in...

Centre Hospitalier Universitaire de la Réunion Source

Compare

Other study identifiers

Sponsor study identifier

2016/CHU/15

Study Type

observational

Actual enrollment (reported)

100,000

Locations

1 country

Sites

1

Timeline

Study Start

December 1, 2017

Actual (reported)

Primary Completion

April 30, 2018

Actual (reported)

Study Completion

April 30, 2018

Actual (reported)

Brief Summary

The question posed by this project is that of the regional estimate of the relative importance of the risk factors of the main pathologies. Our hypothesis is that these risk factors are of different relative importance in Reunion Island compared to metropolitan France.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 100,000 participants
Study completion date: April 30, 2018
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
November 24, 2017
Actual (reported)
First Posted
November 29, 2017
Actual (reported)
Study Start
December 1, 2017
Actual (reported)
Primary Completion
April 30, 2018
Actual (reported)
Study Completion
April 30, 2018
Actual (reported)

Last Updated: September 6, 2018
Status Verified: September 2018
Last Update Submitted: September 4, 2018

Conditions

Disability or Chronic Disease Leading to Disablement

Outcome Measures

Primary Outcomes (1)

Quantity of DALY lost for each risk factor
Risk factors associated to the most prevalent diseases
2 months after legal and ethical agreements

Eligibility Criteria

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Population living in Reunion Island

You may qualify if:

The whole population living in Reunion Island

You may not qualify if:

Sponsors & Collaborators

Centre Hospitalier Universitaire de la Réunion
Otherlead

Study Sites (1)

Olivier MAILLARD

Saint-Pierre, Reunion, 97448, France

Study Officials

Laetitia Huiart, MD
Luxembourg Institute of Health
STUDY DIRECTOR

Enrollment

100,000 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

November 24, 2017

First Posted

November 29, 2017

Study Start

December 1, 2017

Actual (reported)

NCT04836624

Co-designing Personalised Assistive Technology

Not ApplicableCompleted

NCT03263169

Community-based Personalized Care and QOL

Unknown

NCT04709783

Implementing 3-Step Workout for Life in Home Health

Not ApplicableTerminated

NCT05713149

Treatment of Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and Anti-bacterial Agents

Recruiting

People not living in Reunion Island

Contact the study team to confirm eligibility.

Primary Completion

April 30, 2018

Actual (reported)

Study Completion

April 30, 2018

Actual (reported)

Last Updated

September 6, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT03357302
Data provider: ClinicalTrials.gov
Source updated: 2018-09-06
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:36:35 UTC

Locations

FR(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations